Scott Akamine SEC EDGAR Filings (CIK 0001816720)

SEC EDGAR filings, ownership reports, and insider transactions for Scott Akamine.

Business address
C/O Aeon Biopharma, Inc., 4040 Macarthur Blvd., Suite 260, Newport Beach, CA, 92660
Get insider transactions for this reporting owner
Scott Akamine has filed 11 SEC EDGAR filings since 28 May 2021

Latest Filings

Recent SEC filings for Scott Akamine including 4, 144, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 05 Aug 2024 01 Aug 2024 001-39311
4 Open 4 document View SEC filing for 4 4 23 Jan 2024 19 Jan 2024 001-39311
4 Open 4 document View SEC filing for 4 4 21 Dec 2023 19 Dec 2023 001-39311
4 Open 4 document View SEC filing for 4 4 07 Dec 2023 05 Dec 2023 001-39311
144 Open 144 document View SEC filing for 144 07 Dec 2023
144 Open 144 document View SEC filing for 144 05 Dec 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Feb 2023 06 Feb 2023 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Aug 2022 08 Aug 2022 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Feb 2022 09 Feb 2022 001-39311
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jun 2021 01 Jun 2021 001-39311
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 28 May 2021 24 May 2021 001-39311

About this filer

Scott Akamine files with the SEC under CIK 0001816720. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages